KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exelon (EXC) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Exelon (EXC) over the last 17 years, with Q4 2025 value amounting to $626.0 million.

  • Exelon's Cash & Equivalents rose 1571.16% to $626.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $626.0 million, marking a year-over-year increase of 1571.16%. This contributed to the annual value of $626.0 million for FY2025, which is 1571.16% up from last year.
  • Latest data reveals that Exelon reported Cash & Equivalents of $626.0 million as of Q4 2025, which was up 1571.16% from $1.5 billion recorded in Q3 2025.
  • In the past 5 years, Exelon's Cash & Equivalents registered a high of $3.0 billion during Q3 2021, and its lowest value of $435.0 million during Q2 2023.
  • For the 5-year period, Exelon's Cash & Equivalents averaged around $1.0 billion, with its median value being $722.0 million (2024).
  • In the last 5 years, Exelon's Cash & Equivalents crashed by 7891.76% in 2023 and then surged by 14886.36% in 2025.
  • Exelon's Cash & Equivalents (Quarter) stood at $672.0 million in 2021, then decreased by 15.77% to $566.0 million in 2022, then dropped by 14.84% to $482.0 million in 2023, then rose by 12.24% to $541.0 million in 2024, then rose by 15.71% to $626.0 million in 2025.
  • Its Cash & Equivalents stands at $626.0 million for Q4 2025, versus $1.5 billion for Q3 2025 and $724.0 million for Q2 2025.